首页 | 本学科首页   官方微博 | 高级检索  
检索        

白细胞介素-15在狼疮性肾炎活动病变中的临床意义
引用本文:LIANG Liu-qin,许韩师,YE Yu-jin,詹钟平,YANG Xiu-yan.白细胞介素-15在狼疮性肾炎活动病变中的临床意义[J].中国病理生理杂志,2008,24(8):1581-1584.
作者姓名:LIANG Liu-qin  许韩师  YE Yu-jin  詹钟平  YANG Xiu-yan
作者单位:中山大学附属第一医院风湿免疫内科, 广东 广州 510080
基金项目:国家自然科学基金,广东省科技计划
摘    要:目的:检测狼疮肾炎(LN)患者外周血白细胞介素15(IL-15)水平,并进一步分析其与临床有关指标的关系及治疗前后的变化。方法:用酶联免疫吸附法(ELISA)方法检测外周血IL-15水平;采用梯度密度离心法分离外周血单个核细胞(PBMCs);并研究地塞米松对体外培养的活动期LN患者PBMCs分泌IL-15、IgG和dsDNA抗体的影响。结果:(1)LN组患者血清IL-15水平显著高于正常对照组(P<0.01),活动期LN患者血清IL-15水平显著高于缓解期患者(P<0.05)。(2)活动期LN患者血清IL-15水平与SLE活动性指数(SLEDAI)、抗dsDNA抗体、24 h尿蛋白排泄量呈正相关关系,与补体C3呈负相关关系,而与血肌酐无相关关系。(3)激素联合环磷酰胺系统治疗活动期LN患者12周,治疗后随病情缓解血清IL-15水平明显下降。(4)体外培养的活动期LN患者PBMCs分泌IL-15、IgG、dsDNA抗体均显著高于正常对照组,而且IL-15分泌与dsDNA抗体和IgG合成呈正相关关系;地塞米松可明显抑制活动期LN患者PBMCs合成IL-15、IgG、dsDNA抗体。结论:LN患者外周血IL-15水平显著增高,IL-15可能参与LN的病理生理过程;血清IL-15水平检测可作为判断LN是否活动的指标之一。

关 键 词:狼疮肾炎  白细胞介素15  地塞米松  
收稿时间:2008-1-2
修稿时间:2008-4-14

Clinical significance of elevated serum interleukin 15 in patients with active lupus nephritis
LIANG Liu-qin,XU Han-shi,YE Yu-jin,ZHAN Zhong-ping,YANG Xiu-yan.Clinical significance of elevated serum interleukin 15 in patients with active lupus nephritis[J].Chinese Journal of Pathophysiology,2008,24(8):1581-1584.
Authors:LIANG Liu-qin  XU Han-shi  YE Yu-jin  ZHAN Zhong-ping  YANG Xiu-yan
Institution:Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. E-mail: lliuq@mail.sysu.edu.cn
Abstract:AIM: To detect interleukin 15 (IL-15) levels in peripheral blood from patients with active lupus nephritis and investigate its clinical significance. METHODS: IL-15 level was determined by enzyme linked immunosorbent assay (ELISA). The peripheral blood mononuclear cells (PBMCs) were isolated with grads density abaxiality. The inhibitory effects of dexamethasone on production of IL-15, IgG and anti-dsDNA antibody in cultured PBMCs from LN patients were also investigated. RESULTS: (1) Serum IL-15 level in LN patients was significantly higher than that in normal controls (P<0.01). Serum IL-15 level in active LN patients was significantly higher than that in remised patients (P<0.05). (2) Serum IL-15 level was positively correlated with SLEDAI, anti-dsDNA antibody and 24 h urine protein excretion in active LN patients. (3) Serum IL-15 level was significantly reduced in LN patients treated with combination of cyclophosphamide (CTX) and steroid for 12 weeks. (4) Secretion of IL-15, IgG and dsDNA antibody in cultured PBMCs from active LN patients was significantly higher than that in normal control group, and IL-15 level in supernatant of cultured PBMCs from active LN patients was positively correlated with IgG and dsDNA antibody. Dexamethasone inhibited the secretion of IL-15, IgG and dsDNA antibody in cultured PBMCs from LN patients. CONCLUSION: Serum IL-15 level in patients with active lupus nephritis is significantly elevated, suggesting that IL-15 may be involved in the pathophysiological process of LN. IL-15 may be used as an index to assess the activity of LN.
Keywords:Lupus nephritis  Interleukin-15  Dexamethasone
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号